Related Experiment Video
Updated: Jul 5, 2026

In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor
Yasar Kucukardali1, Sebnem Aydogdu, Namik Ozmen
1Department of Internal Medicine, Gulhane School of Medicine, Haydarpasha Training Hospital, Istanbul, Turkey. yasarkardali@yahoo.com <yasarkardali@yahoo.com>
Insights
Elevated vascular endothelial growth factor (VEGF) in patients with coronary artery disease indicates critical blockages. Increased VEGF may signal the need for revascularization in these patients.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
Background:
- Coronary artery disease (CAD) is a significant health concern.
- Vascular Endothelial Growth Factor (VEGF) is known to increase with coronary artery occlusion in animal models.
- The relationship between VEGF and human CAD, particularly the degree of coronary occlusion, requires further investigation.
Purpose of the Study:
- To investigate the correlation between the degree of coronary artery occlusion and plasma VEGF levels in patients with established CAD.
- To assess the relationship between plasma VEGF and other cardiac risk factors.
Main Methods:
- The study included 77 patients with established coronary artery disease.
- Patients were categorized into a control group (normal angiography) and groups with abnormal angiography (critical and non-critical lesions).
- Plasma VEGF levels were measured and compared across groups, with logistic regression analysis performed.
Main Results:
- Plasma VEGF levels were significantly higher in patients with critical coronary lesions compared to controls.
- A negative correlation was observed between VEGF and hemoglobin, and a positive correlation with age.
- No significant relationship was found between plasma VEGF and other common cardiac risk parameters.
Conclusions:
- Elevated plasma VEGF levels in CAD patients may indicate critical coronary lesions.
- VEGF may serve as a potential biomarker for identifying patients who require revascularization.
Objective:
It has been known that ischemia or occlusion of coronary arteries in animal models increases the production of vascular endothelial growth factor (VEGF); however, little is known about the relationship between coronary artery disease and VEGF in humans. In this study, our aim was to evaluate the relationships between the degree of coronary occlusion and plasma VEGF level as well as other risk factors, including age, weight, arterial blood pressure, cholesterol, triglyceride, blood glucose, and high-sensitive C-reactive protein (hsCRP) in patients with established coronary artery disease.
Materials And Methods:
Our study group consisted of 77 patients. Of these, 38 patients had normal coronary angiography (control group; group C) and 39 had abnormal angiography (17 critical lesion; group CL, 22 noncritical lesion; non-CL group).
Results:
Plasma VEGF level was 116.95+/-30.12 pg/ml in the control group, 212.47+/-75.28 pg/ml in group CL, and 138.89+/-45.18 pg/ml in the non-CL group. Plasma VEGF level of group C was found to be lower than that of group CL (P<.05), but the difference between groups C and non-CL was insignificant (P>.05). However, logistic regression analysis showed that VEGF level of group CL was significantly higher (P<.001). There was a negative correlation between VEGF and haemoglobin (r=-0.58, P<.01), and positive correlation between VEGF and age (r=0.29, P<.04). There was no relationship between plasma VEGF level and other cardiac risk parameters. Group CL had a higher level of total and LDL-cholesterol levels.
Conclusion:
Increased plasma VEGF levels in patients with coronary artery disease may point that the coronary lesion is critical, and VEGF increase in patients with established coronary artery disease may be used as an indicator of the need for revascularization.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Regulation of Angiogenesis and Blood Supply
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations

